CNY 21.63
(1.07%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 765.94 Million CNY | 81.9% |
2022 | 421.07 Million CNY | -8.85% |
2021 | 461.94 Million CNY | 48.68% |
2020 | 310.68 Million CNY | 41.15% |
2019 | 220.11 Million CNY | 7.73% |
2018 | 204.31 Million CNY | -13.49% |
2017 | 236.18 Million CNY | -3.82% |
2016 | 245.55 Million CNY | 31.66% |
2015 | 186.51 Million CNY | -12.1% |
2014 | 212.19 Million CNY | 9.5% |
2013 | 193.78 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.07 Billion CNY | 24.31% |
2024 Q1 | 867.51 Million CNY | 13.26% |
2024 Q3 | 1.04 Billion CNY | -2.9% |
2023 FY | 765.94 Million CNY | 81.9% |
2023 Q4 | 765.94 Million CNY | 5.59% |
2023 Q2 | 584.11 Million CNY | 25.02% |
2023 Q3 | 725.38 Million CNY | 24.18% |
2023 Q1 | 467.21 Million CNY | 10.96% |
2022 Q2 | 563.76 Million CNY | 10.77% |
2022 FY | 421.07 Million CNY | -8.85% |
2022 Q4 | 421.07 Million CNY | -14.42% |
2022 Q3 | 492.02 Million CNY | -12.73% |
2022 Q1 | 508.95 Million CNY | 10.18% |
2021 Q4 | 461.94 Million CNY | 8.88% |
2021 Q2 | 511.77 Million CNY | 11.41% |
2021 FY | 461.94 Million CNY | 48.68% |
2021 Q1 | 459.36 Million CNY | 47.86% |
2021 Q3 | 424.25 Million CNY | -17.1% |
2020 Q2 | 283.31 Million CNY | 32.33% |
2020 Q4 | 310.68 Million CNY | 11.75% |
2020 Q1 | 214.09 Million CNY | -2.73% |
2020 FY | 310.68 Million CNY | 41.15% |
2020 Q3 | 278.01 Million CNY | -1.87% |
2019 Q3 | 224.56 Million CNY | -9.32% |
2019 FY | 220.11 Million CNY | 7.73% |
2019 Q4 | 220.11 Million CNY | -1.98% |
2019 Q1 | 206.32 Million CNY | 0.98% |
2019 Q2 | 247.65 Million CNY | 20.03% |
2018 Q2 | 231.65 Million CNY | -2.92% |
2018 FY | 204.31 Million CNY | -13.49% |
2018 Q4 | 204.31 Million CNY | -15.79% |
2018 Q3 | 242.61 Million CNY | 4.73% |
2018 Q1 | 238.63 Million CNY | 1.04% |
2017 FY | 236.18 Million CNY | -3.82% |
2017 Q1 | - CNY | -100.0% |
2017 Q2 | 218.58 Million CNY | 0.0% |
2017 Q4 | 236.18 Million CNY | 0.0% |
2016 FY | 245.55 Million CNY | 31.66% |
2016 Q2 | 247.63 Million CNY | 0.0% |
2016 Q1 | 247.63 Million CNY | 0.0% |
2016 Q4 | 245.55 Million CNY | 0.0% |
2015 FY | 186.51 Million CNY | -12.1% |
2014 FY | 212.19 Million CNY | 9.5% |
2013 FY | 193.78 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Liuzhou Liangmianzhen Co., Ltd. | 505.75 Million CNY | -51.447% |
Shanghai Jahwa United Co., Ltd. | 3.76 Billion CNY | 79.651% |
Henan Rebecca Hair Products Co., Ltd. | 2.53 Billion CNY | 69.756% |
RUNBEN BIOTECHNOLOGY | 97.61 Million CNY | -684.681% |
Proya Cosmetics Co.,Ltd. | 2.91 Billion CNY | 73.736% |
Lafang China Co.,Ltd | 195.21 Million CNY | -292.352% |
Shanghai Flyco Electrical Appliance Co., Ltd. | 806.72 Million CNY | 5.055% |
Guangdong Marubi Biotechnology Co., Ltd. | 1.02 Billion CNY | 25.567% |
Hangzhou Haoyue Personal Care Co., Ltd | 1.42 Billion CNY | 46.413% |